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Background: In bacteria-induced glomerulonephritis, Toll-like receptor 4 (TLR4) activation by lipopolysaccharide
(LPS, a key component of the outer membranes of Gram-negative bacteria) can increase oxidative stress and the
expression of vascular cell adhesion molecule-1 (VCAM-1), which recruits leukocytes to the glomerular mesangium.
However, the mechanisms underlying VCAM-1 expression induced by LPS are still unclear in human renal
mesangial cells (HRMCs).
Results: We demonstrated that LPS induced VCAM-1 mRNA and protein levels associated with an increase in the
promoter activity of VCAM-1, determined by Western blot, RT-PCR, and promoter assay. LPS-induced responses
were inhibited by transfection with siRNAs of TLR4, myeloid differentiation factor 88 (MyD88), Nox2, Nox4, p47phox,
c-Src, p38 MAPK, activating transcription factor 2 (ATF2), and p300 or pretreatment with the inhibitors of reactive
oxygen species (ROS, edaravone), NADPH oxidase [apocynin (APO) or diphenyleneiodonium chloride (DPI)], c-Src
(PP1), p38 MAPK (SB202190), and p300 (GR343). LPS induced NADPH oxidase activation, ROS production, and
p47phox translocation from the cytosol to the membrane, which were reduced by PP1 or c-Src siRNA. We observed
that LPS induced TLR4, MyD88, c-Src, and p47phox complex formation determined by co-immunoprecipitation and
Western blot. We further demonstrated that LPS stimulated ATF2 and p300 phosphorylation and complex
formation via a c-Src/NADPH oxidase/ROS/p38 MAPK pathway. Up-regulation of VCAM-1 led to enhancing
monocyte adhesion to HRMCs challenged with LPS, which was inhibited by siRNAs of c-Src, p47phox, p38 MAPK,
ATF2, and p300 or pretreatment with an anti-VCAM-1 neutralizing antibody.
Conclusions: In HRMCs, LPS-induced VCAM-1 expression was, at least in part, mediated through a TLR4/MyD88/
c-Src/NADPH oxidase/ROS/p38 MAPK-dependent p300 and ATF2 pathway associated with recruitment of monocyte
adhesion to kidney. Blockade of these pathways may reduce monocyte adhesion via VCAM-1 suppression and
attenuation of the inflammatory responses in renal diseases.
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Mesangial cells (MCs) response to various pathological
stimuli associated with the main events of glomerular in-
flammation, including leukocyte infiltration, cell prolifera-
tion, and fibrosis, which were predominantly mediated
through induction of adhesion molecules [1,2]. In
bacteria-induced glomerulonephritis, lipopolysaccharide
(LPS, a key component of the outer membranes of Gram-
negative bacteria) stimulated VCAM-1 induction in the
murine glomerular mesangium [3]. It has been also
reported that Toll-like receptor 4 (TLR4) activation by
LPS increased the expression of adhesion molecules, such
as VCAM-1 which recruits leucocytes to the kidney [4,5].
Reactive oxygen species (ROS) are known to play a
prominent role in the pathogenesis of various renal disor-
ders, such as nephropathy [6], renal ischemia [7], and
renal fibrosis [8]. Nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase is an important enzymatic
source for the production of ROS under various patho-
logic conditions [9]. NADPH oxidase-derived ROS have
been shown to induce monocyte chemoattractant protein-
1 expression in MCs leading to nephropathy [10]. Acti-
vated NADPH oxidase is a multimeric protein complex,
including p47phox cytosolic subunits. It has been shown
that the phosphorylation of p47phox results in its mem-
brane translocation and activation of NADPH oxidase
[11]. It has been reported that ROS generation is neces-
sary for VCAM-1 induction in IL-1β-treated human tra-
cheal smooth muscle cells [12]. The role of ROS in
mediating VCAM-1 expression induced by LPS remains
to be clarified in human renal mesangial cells (HRMCs).
Src family kinases have been shown to mediate NADPH
oxidase activation and ROS generation in lung endothelial
cells [13]. c-Src has also been shown to stimulate the
phosphorylation of p47phox and therefore increased
NADPH oxidase-derived ROS in VCAM-1 expression in
IL-1β-treated human tracheal smooth muscle cells [12].
However, the mechanisms underlying NADPH oxidase ac-
tivation and ROS production regulated by p47phox trans-
location mediated through c-Src in LPS-induced VCAM-
1 expression are also unclear in HRMCs. On the other
hand, it has also been shown that ROS stimulate p38
MAPK phosphorylation in opossum kidney cells [14].
However, the role of p38 MAPK in NADPH oxidase-
derived ROS-dependent VCAM-1 expression induced by
LPS is still unclear in HRMCs.
The promoter region of VCAM-1 possesses a series of
functional element, including activator protein-1 (AP-1)
binding sites that are essential for induction of VCAM-1
associated with inflammatory responses [15]. It has been
established that various stimuli, such as bacterial infec-
tions have been shown to induce AP-1 activity [16]. AP-1
is a dimeric protein, consisting of dimers composed of
members of either ATF, Jun, or Fos families of proteins[17]. However, the role of ATF2 in LPS-induced VCAM-1
expression is still unknown in HRMCs.
In addressing these questions, experiments were under-
taken to investigate the mechanisms underlying LPS-
induced VCAM-1 expression mediated through NADPH
oxidase activation/ROS generation in HRMCs. These find-
ings suggest that in HRMCs, LPS-induced VCAM-1 ex-
pression was, at least in part, mediated through a TLR4/
MyD88/c-Src/NADPH oxidase/ROS/p38 MAPK-dependent
p300 and ATF2 pathway relevant to recruitment of mono-
cyte adhesion to kidney. These results provide new
insights into the mechanisms of LPS action on HRMCs to
regulate the expression of VCAM-1 and thus exaggerates
the inflammatory responses.
Results
LPS induces VCAM-1 expression via a
TLR4/MyD88-dependent pathway
To investigate the effects of LPS on VCAM-1 expression,
HRMCs were treated with various concentrations of LPS
(100, 10, 1, and 0.1 μg/ml). As shown in Figure 1A, LPS
markedly induced VCAM-1 expression in a time- and
concentration-dependent manner in HRMCs. TLR4 is an
essential signaling receptor for LPS [18]. Indeed, we also
demonstrated that LPS-induced VCAM-1 expression was
inhibited by transfection with TLR4 siRNA, but not TLR2
siRNA in HRMCs (Figure 1B). In addition, LPS-induced
VCAM-1 promoter activity was also reduced by transfec-
tion with TLR4 siRNA (Figure 1C). On the other hand, we
demonstrated that LPS could directly induce TLR4 mRNA
expression in a time-dependent manner in HRMCs
(Figure 1D). The TLR4 signaling cascade initiated follow-
ing LPS binding is enhanced by homodimerization of the
receptor and subsequent recruitment of TIR domain-
containing adaptor molecules (TIRAP) to the cytoplasmic
domain of the receptor [19]. These adaptors include mye-
loid differentiation factor 88 (MyD88), MyD88 adaptor-
like protein (Mal), TIR-containing adaptor inducing IFNβ
(TRIF), also known as TIRAP-1 (TICAM-1), and TRIF-
related adaptor molecule (TRAM). Activation of TLR4
leads to stimulation of both MyD88-dependent and
MyD88-independent pathways [19]. Moreover, in HRMCs,
we showed that LPS-induced VCAM-1 expression was
inhibited by transfection with MyD88 siRNA (Figure 1E).
These results suggested that LPS induced VCAM-1
expression through a TLR4/MyD88-dependent signaling
pathway.
LPS induces NADPH oxidase activation and ROS
production in HRMCs
NADPH oxidase is an important enzymatic source for
the production of ROS under various pathologic condi-
tions [9]. LPS has been shown to activate NADPH oxi-
dase and stimulate ROS generation in human tracheal
Figure 1 LPS induces VCAM-1 expression via TLR4/MyD88 in HRMCs. (A) Cells were treated with LPS for the indicated time intervals. The
protein levels of VCAM-1 were determined by Western blot. (B) Cells were transfected with TLR2 siRNA, TLR4 siRNA, or scrambled siRNA, and then
incubated with LPS (10 μg/ml) for 8 h. The levels of TLR4, TLR2, and VCAM-1 protein were determined by Western blot. (C) Cells were transiently
transfected with VCAM-1-luc reporter gene and TLR2 siRNA, TLR4 siRNA, or scrambled siRNA, and then incubated with LPS for 6 h. The VCAM-1
promoter activity was determined in the cell lysates. (D) Cells were incubated with LPS (10 μg/ml) for the indicated time intervals. The mRNA
expression of TLR4 was determined by RT-PCR. (E) Cells were transfected with MyD88 siRNA or scrambled siRNA, and then incubated with LPS
(10 μg/ml) for 8 h. The levels of MyD88 and VCAM-1 protein were determined by Western blot. All figures are representative of three
independent experiments, performed in duplicate or triplicate. Data are expressed as means ± SEM. *P < 0.05; #P < 0.01, as compared with the cells
exposed to vehicle alone (A, D). #P < 0.01, as compared with the cells exposed to scrambled siRNA alone [B (upper panel), E (upper panel)] or
LPS + scrambled siRNA [B (lower panel), C, E (lower panel)].
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LPS-induced VCAM-1 expression was mediated through
NADPH oxidase/ROS. As shown in Figsure 2A and B,
pretreatment with the inhibitor of NADPH oxidase
[apocynin (APO) or diphenyleneiodonium chloride
(DPI)] or a ROS scavenger (edaravone, MCI-186) mark-
edly inhibited LPS-induced VCAM-1 protein and mRNA
expression and promoter activity in HRMCs. Activated
NADPH oxidase is a multimeric protein complex con-
sisting of at least three cytosolic subunits of p47phox,
p67phox, and p40phox. Phosphorylation of p47phox leads
to a conformational change allowing its interaction with
p22phox [20]. It has been demonstrated that p47phox
organizes the translocation of other cytosolic factors,
hence its designation as “organizer subunit” [20]. Here,
we showed that transfection with p47phox siRNA inhib-
ited LPS-mediated VCAM-1 induction (Figure 2C). In-
deed, in cultured HRMCs, Nox2, Nox4, and Nox5 wereexpressed (data not shown). Moreover, in this study, we
also observed that transfection with siRNA of Nox2 or
Nox4 markedly reduced LPS-induced VCAM-1 expres-
sion in HRMCs (Figures 2D and E). Thus, we suggested
that LPS-induced ROS generation was, at least in part,
mediated via Nox2 or Nox4 activation in these cells. We
further demonstrated that LPS stimulated NADPH oxidase
activation and ROS, including H2O2 and O2
•− production in
HRMCs (Figures 2F and G). Moreover, pretreatment with
APO, DPI, or edaravone inhibited LPS-enhanced ROS ge-
neration in HRMCs (Figure 2H), suggesting that LPS sti-
mulated ROS production via NADPH oxidase activation.
We next investigated the effect of LPS on translocation of
p47phox in HRMCs. Cells were treated with 10 μg/ml LPS
for the indicated time intervals. The membrane and cyto-
solic fractions were prepared and subjected to Western
blot analysis using an anti-p47phox antibody. As shown in
Figure 2I, LPS stimulated a time-dependent increase in
Figure 2 LPS induces VCAM-1 expression via NADPH oxidase/ROS. (A) Cells were pretreated with MCI-186 (MCI, 100 μM), APO (100 μM), or
DPI (10 μM), and then incubated with LPS for 8 h. The levels of VCAM-1 protein were determined. (B) Cells were pretreated with MCI-186 (MCI),
APO, or DPI, and then incubated with LPS for 4 h or 6 h. The mRNA levels and promoter activity of VCAM-1 were determined. (C, D, E) Cells were
transfected with p47phox, Nox2, Nox4, or scrambled siRNA, and then incubated with LPS for 8 h. The protein levels of p47phox, Nox2, Nox4, and
VCAM-1 were determined. (F) Cells were stimulated with LPS for the indicated times. NADPH oxidase and ROS generation were measured. (G)
DHE fluorescence image after 30 min of stimulation with LPS. (H) Cells were pretreated with MCI-186 (MCI), APO, or DPI, and then treated with
LPS for 30 min. ROS generation was measured. (I) Cells were stimulated with LPS for the indicated times. The membrane and cytosolic fractions
were prepared and subjected to Western blot using an anti-p47phox antibody. Gsα and GAPDH were used as a marker protein for membrane and
cytosolic fractions, respectively. All figures are representative of three independent experiments, performed in duplicate. Data are expressed as
means ± SEM. *P < 0.05; #P < 0.01, as compared with the cells exposed to LPS alone (A, B, H), scrambled siRNA alone (upper panels of C, D, E),
LPS + scrambled siRNA (lower panels of C, D, E), or vehicle alone (F, I).
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These data demonstrated that LPS induced ROS gene-
ration through a NADPH oxidase-dependent signaling
leading to VCAM-1 expression in HRMCs.
LPS enhances NADPH oxidase activation and ROS
generation via c-Src in HRMCs
Recent studies have shown that TLR4 signaling is coupled
to c-Src family kinase activation, tyrosine phosphorylation
of zonula adherens proteins, and opening of the paracellu-
lar pathway in human lung microvascular endothelia
[21,22]. We investigated whether c-Src was involved in the
induction of VCAM-1 in response to LPS. As shown in
Figures 3A and B, pretreatment with the inhibitor of c-Src
(PP1) reduced LPS-induced VCAM-1 protein and mRNA
expression and promoter activity. In addition, transfection
with c-Src siRNA also inhibited LPS-induced VCAM-1
expression (Figure 3C). LPS could stimulate c-Src phos-
phorylation, which was inhibited by pretreatment with
PP1 (Figure 3D). c-Src has been shown to regulate ROS
generation in human tracheal smooth muscle cells [9].
Moreover, we also found that LPS-induced p47phox trans-
location, NADPH oxidase activation, and ROS generation
were inhibited by transfection with c-Src siRNA
(Figures 3E and F). We further investigated the physical
association of TLR4, c-Src, and p47phox in LPS-induced
ROS generation and VCAM-1 expression. As shown in
Figure 3G, the protein levels of TLR4 and p47phox were
time-dependently increased in c-Src-immunoprecipitated
complex in LPS-treated HRMCs. Thus, these data sug-
gested that LPS-induced VCAM-1 expression is mediated
through c-Src-dependent NADPH oxidase/ROS generation
in HRMCs.
LPS induces VCAM-1 expression via NADPH oxidase/
ROS-dependent p38 MAPK activation in HRMCs
MAPKs, including p38 MAPK, JNK1/2, and p42/p44
MAPK have been shown to regulate VCAM-1 induction in
various cell types [20,23-25]. Here, we determined whether
these three MAPKs were involved in LPS-induced VCAM-
1 expression in HRMCs. As shown in Figures 4A and B,
pretreatment with the inhibitor of p38 MAPK (SB202190),
JNK1/2 (SP600125), or MEK1/2 (U0126) markedly inhib-
ited LPS-induced VCAM-1 protein and mRNA expression
and promoter activity in HRMCs. It has been shown that
ROS-dependent activation of MAPKs is required for in-
flammatory responses [26-28]. In HRMCs, LPS-stimulated
p38 MAPK phosphorylation was inhibited by transfection
with either c-Src siRNA or p47phox siRNA (Figure 4C).
However, pretreatment with PP1, but not edaravone inhib-
ited LPS-induced p42/p44 MAPK and JNK1/2 phosphoryl-
ation (Figures 4D and E). Finally, the involvement of p38
MAPK in LPS-induced VCAM-1 expression was further
confirmed by transfection with p38 MAPK siRNA. Asshown in Figure 4F, transfection with p38 siRNA reduced
the expression of total p38 MAPK protein and subsequently
attenuated VCAM-1 expression induced by LPS. These
results indicated that p38 MAPK phosphorylation involved
in VCAM-1 induction by LPS was mediated through a c-
Src/NADPH oxidase/ROS-dependent cascade in HRMCs.
LPS induces VCAM-1 expression via p38 MAPK-dependent
ATF2 activation
ATF2 is activated by inflammatory signals transduced by
the p38 MAPK pathway [29]. In addition, LPS has also
been shown to regulate VCAM-1 expression via an ATF2
signaling [30]. In this study, we investigated whether
ATF2 activation was involved in LPS-induced VCAM-1
expression in HRMCs. As shown in Figures 5A, B and C,
transfection with ATF2 siRNA inhibited LPS-induced
VCAM-1 protein and mRNA expression and promoter
activity in HRMCs. On the other hand, we demonstrated
that LPS time-dependently stimulated ATF2 phosphoryl-
ation, which was inhibited by transfection with siRNA of
c-Src, p47phox, or p38 MAPK in HRMCs (Figures 5D and
E). We found that LPS induced ATF2 translocation from
the cytosol to the nucleus, which was inhibited by pretreat-
ment with either PP1 or edaravone (MCI-186) (Figure 5F).
These data suggested that ATF2 phosphorylation involved
in LPS-induced VCAM-1 expression is mediated through c-
Src/NADPH oxidase/ROS/p38 MAPK pathway in HRMCs.
LPS induces VCAM-1 expression via the formation of an
ATF2/p300 complex
p300 has been shown to be involved in VCAM-1 induction
[12]. Here, we investigated whether LPS could induce
VCAM-1 expression via p300 in HRMCs. As shown in
Figures 6A, B and C, pretreatment with the inhibitor of
p300 (GR343) significantly reduced LPS-induced VCAM-1
protein and mRNA expression and promoter activity. On
the other hand, we also demonstrated that transfection with
p300 siRNA down-regulated p300 protein levels and LPS-
induced VCAM-1 expression (Figure 6D). LPS also stimu-
lated p300 phosphorylation in a time-dependent manner in
HRMCs, which was inhibited by pretreatment with GR343,
PP1, edaravone (MCI-186), apocynin, or SB202190
(Figures 6E and F). We further investigated the physical
association between p300 and ATF2 in LPS-treated
HRMCs. As shown in Figure 6G, cells were stimulated
with 10 μg/ml LPS for the indicated time intervals. The
cell lysates were subjected to immunoprecipitation using
an anti-p300 antibody, and then the immunoprecipitates
were analyzed by Western blotting using an anti-p300 or
anti-ATF2 antibody. The protein levels of ATF2 were
time-dependently increased in p300-immunoprecipitated
complex. These results suggested that LPS triggered the
interaction between p300 and ATF2 leading to VCAM-1
expression in HRMCs.
Figure 3 LPS induces VCAM-1 expression via c-Src. (A) Cells were pretreated with PP1, and then incubated with LPS for 8 h. VCAM-1 protein
levels were determined. (B) Cells were pretreated with PP1, and then incubated with LPS for 4 h or 6 h. The mRNA levels and promoter activity
of VCAM-1 were determined. (C) Cells were transfected with c-Src siRNA, and then incubated with LPS for 8 h. The protein levels of c-Src and
VCAM-1 were determined. (D) Cells were pretreated without or with PP1 (1 μM), and then treated with LPS for the indicated times or 10 min. The
expression of phospho-c-Src was determined. (E) Cells were transfected with c-Src siRNA, and then stimulated with LPS for 30 min. The NADPH
oxidase activity and ROS generation were determined. (F) Cells were transfected with c-Src siRNA, and then incubated with LPS for 30 min. The
membrane fractions were prepared and subjected to Western blot using an anti-p47phox antibody. (G) Cells were treated with LPS for the
indicated times. The cell lysates were subjected to immunoprecipitation using an anti-c-Src antibody, and then the immunoprecipitates were
analyzed by Western blot using an anti-TLR4, anti-p47phox, or anti-c-Src antibody. All figures are representative of three independent experiments,
performed in duplicate. Data are expressed as means ± SEM. *P < 0.05; #P < 0.01, as compared with the cells exposed to LPS alone [A, B, D (lower
panel)], scrambled siRNA alone (C, upper panel), LPS + scrambled siRNA [C (lower panel), E, F], or vehicle alone [D (upper panel), G].
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HRMCs challenged with LPS
We investigated the roles of c-Src, p47phox, p38
MAPK, ATF2, and p300 in the adhesion of THP-1
cells to HRMCs challenged with LPS. As shown inFigure 7, transfection with siRNAs of c-Src, p47phox,
p38 MAPK, ATF2, and p300 or preincubation with an
anti-VCAM-1 neutralizing antibody markedly inhibited
the adhesion of THP-1 cells to HRMCs treated with
LPS.
Figure 4 LPS induces VCAM-1 expression via ROS/p38 MAPK. (A) Cells were pretreated with SB202190, U0126, or SP600125, and then
incubated with LPS for 8 h. VCAM-1 protein levels were determined. (B) Cells were pretreated with SB202190, U0126, or SP600125, and then
incubated with LPS for 4 h or 6 h. mRNA levels and promoter activity of VCAM-1 were determined. (C) Cells were treated with LPS for the
indicated times or transfected with siRNA of c-Src, p47phox, or p38 MAPK, and then treated with LPS for 1 h. Phospho-p38 MAPK expression was
determined. (D) Cells were treated with LPS for the indicated times or pretreated with edaravone (Eda, 100 μM), PP1 (1 μM), or U0126 (U0, 1 μM),
and then treated with LPS for 5 min. Phospho-p42/p44 MAPK expression was determined. (E) Cells were treated with LPS for the indicated times
or pretreated with edaravone (Eda), PP1, or SP600125 (SP), and then treated with LPS for 1 h. The expression of phospho-JNK1/2 was determined.
(F) Cells were transfected with p38 MAPK siRNA, and then incubated with LPS for 8 h. Protein levels of p38 MAPK and VCAM-1 were determined.
All figures are representative of three independent experiments, performed in duplicate. Data are expressed as means ± SEM. *P < 0.05; #P < 0.01,
as compared with the cells exposed to LPS alone (A, B, lower panels of D and E), vehicle alone (upper panels of C, D, E), scrambled siRNA alone
(F, upper panel), or LPS + scrambled siRNA (lower panels of C and F).
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Figure 5 LPS induces VCAM-1 expression via p38 MAPK/ATF2 in HRMCs. Cells were transfected with ATF2 siRNA or scrambled siRNA, and
then incubated with LPS for (A) 8 h or (B) 4 h. The levels of VCAM-1 protein (A) and mRNA (B) expression were determined. (C) Cells were
transiently transfected with VCAM-1-luc reporter gene, transfected with ATF2 siRNA or scrambled siRNA, and then incubated with LPS for 6 h. The
VCAM-1 promoter activity was determined. (D) Cells were treated with LPS for the indicated time intervals. The cell lysates were subjected to
Western blot using an anti-phospho-ATF2 or anti-β-actin antibody. (E) Cells were transfected with siRNA of c-Src, p47phox, p38 MAPK, or
scrambled, and then treated with LPS for 90 min. The cell lysates were subjected to Western blot using an anti-phospho-ATF2 or anti-β-actin
antibody. (F) Cells were pretreated with MCI-186 (100 μM) or PP1 (1 μM) for 1 h, and then treated with LPS for 90 min. Cells were fixed, labeled
with an anti-ATF2 antibody, and then FITC-conjugated secondary antibody. Individual cells were imaged. All figures are representative of three
independent experiments, performed in duplicate or triplicate. Data are expressed as means ± SEM. #P < 0.01, as compared with the cells exposed
to scrambled siRNA alone (A, upper panel) or LPS + scrambled siRNA (A, lower panel and E). #P < 0.01, as compared with the cells exposed to LPS
alone (B, C); *P < 0.05; #P < 0.01, as compared with the cells exposed to vehicle alone (D).
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LPS has been shown to stimulate TNF-α production and
ICAM-1 and VCAM-1 expression leading to renal inflam-
matory diseases [3]. LPS-induced VCAM-1 expression has
been shown to be mediated through MAPKs, AP-1, and
NF-κB in various cells types [31,32]. It has been reported
that NADPH oxidase/ROS generation is necessary for
VCAM-1 induction [12]. Thus, these signaling compo-
nents may regulate VCAM-1 induction in response to
LPS in HRMCs. However, the detail mechanisms under-
lying LPS-induced VCAM-1 expression in HRMCs re-
main largely unknown. In this study, our resultsdemonstrated that LPS-induced VCAM-1 expression and
the adhesion of THP-1 cells to HRMCs were mediated
through the p38 MAPK-dependent p300/ATF2 pathway,
which was transactivated by a TLR4/MyD88-dependent c-
Src/NADPH oxidase/ROS cascade in these cells
(Figure 8).
TLRs are type I transmembrane receptors that
expressed on the cell membrane induced by LPS [33].
More than 10 human TLRs have been identified [19].
Moreover, we demonstrated that LPS induced VCAM-1
expression via TLR4 in HRMCs. LPS further directly
induced TLR4 gene expression, suggesting that LPS could
Figure 6 LPS induces VCAM-1 expression via p300. Cells were pretreated with GR343, and then incubated with LPS for (A) 8 h or (B) 4 h.
Levels of VCAM-1 protein (A) and mRNA (B) expression were determined. (C) Cells were pretreated with 1 μM GR343, and then incubated with
LPS for 6 h. VCAM-1 promoter activity was determined. (D) Cells were transfected with p300 siRNA, and then incubated with LPS for 8 h. Protein
levels of p300 and VCAM-1 were determined. (E) Cells were treated with LPS for the indicated times. The cell lysates were subjected to Western
blot using an anti-phospho-p300 antibody. (F) Cells were pretreated with GR343 (GR, 1 μM), PP1 (1 μM), MCI-186 (MCI, 100 μM), APO (100 μM), or
SB202190 (SB, 1 μM), and then treated with LPS for 90 min. The cell lysates were subjected to Western blot using an anti-phospho-p300 antibody.
(G) Cells were treated with LPS for the indicated times. The cell lysates were subjected to immunoprecipitation using an anti-p300 antibody, and
then the immunoprecipitates were analyzed by Western blot using an anti-ATF2 or anti-p300 antibody. All figures are representative of three
independent experiments, performed in duplicate. Data are expressed as means ± SEM. *P < 0.05; #P < 0.01, as compared with the cells exposed to
LPS alone (A, B, C, F), scrambled siRNA alone (D, upper panel), LPS + scrambled siRNA (D, lower panel), or vehicle alone (E, G).
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MyD88 is a cytosolic adapter molecule connecting TLRs
and IL-1Rs to the interleukin-1 receptor-associated kinase
(IRAK) complex. The MyD88- and IRAK-4-dependent
TIR (Toll/IL-1R) pathways lead to the production of pro-
inflammatory cytokines. All human TLRs other than
TLR3 use both MyD88 and IRAK-4 to transduce signals
[19]. We showed that LPS induced VCAM-1 expression
via a TLR4/MyD88-dependent signaling in HRMCs. In
the future, we will further investigate whether IRAK-1,
IRAK-4, or TRAF6 involves in VCAM-1 induction.
Oxidative stress, induced by systemic and intrarenal
generation of ROS can directly exert renal parenchymaldamage and may intensify renal microvascular and func-
tional dysregulation, with a feedforward loop of hypoxia
and ROS generation. Moreover, ROS have been shown to
cause cellular damage or tissue injury, and then mediate
the pathogenesis of various renal disorders, such as renal
ischemia or nephropathy [7,10]. The NADPH oxidase
family members are proteins that transfer electrons across
biological membranes [9]. In general, the electron ac-
ceptor is oxygen and the product of the electron transfer
reaction is a superoxide [20]. Therefore, the biological
function of NADPH oxidase enzymes might be attribut-
able to the production of ROS [20]. Here, we showed that
LPS-induced VCAM-1 expression was inhibited by
Figure 7 LPS enhances the adhesion of THP-1 cells to HRMCs. Cells were transfected with siRNA of c-Src, p47phox, p38 MAPK, ATF2, p300 or
scrambled, or pretreated with anti-VCAM-1 Ab, and then incubated with LPS for 16 h. The THP-1 cells adherence was measured. All figures are
representative of three independent experiments, performed in duplicate. Data are expressed as means ± SEM. #P < 0.01, as compared with the
cells exposed to LPS alone.
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ROS scavenger, suggesting that NADPH oxidase/ROS are
involved in LPS-induced inflammatory responses. Acti-
vated NADPH oxidase is a multimeric protein complex
consisting of at least three cytosolic subunits of p47phox,
p67phox, and p40phox. The p47phox regulatory subunit plays
a critical role in acute activation of NADPH oxidase;
phosphorylation of p47phox is thought to relieve the inhibi-
tory intracellular interactions and permit the binding of
p47phox to p22phox, thereby increasing oxidase activation
[9,20]. Moreover, we found that transfection with p47phox
siRNA markedly reduced LPS-induced VCAM-1 expres-
sion. In addition, LPS also increased the production of
H2O2 and superoxide and the activation of NADPH oxi-
dase in HRMCs. LPS directly stimulated p47phox trans-
location from the cytosol to the membrane. These results
indicated that ROS play a key role in LPS-induced
VCAM-1 expression. In renal mesangial cells, Nox1-5 are
expressed [34,35]. However, in cultured HRMCs, we only
observed that Nox2, Nox4, and Nox5 were expressed
(data not shown). Here, we showed that transfection with
siRNA of Nox2 or Nox4 markedly reduced LPS-induced
VCAM-1 expression in HRMCs. Thus, we suggested that
LPS-induced ROS generation was, at least in part,mediated via Nox2 or Nox4 activation in these cells. In
the future, we will investigate the detail mechanisms of
LPS-regulated Nox2, Nox4, and Nox5 activation and ROS
generation in cultured HRMCs.
Src family kinases are signaling enzymes that have long
been recognized to regulate critical cellular processes,
such as proliferation, survival, migration, and metastasis
[36]. c-Src has been shown to regulate VCAM-1 expres-
sion in various cell types [12,37]. In addition, NADPH oxi-
dase/ROS have been shown to be mediated through c-Src
activation [9,12]. We also established that LPS-induced
VCAM-1 expression, p47phox translocation, NADPH oxi-
dase activity, and ROS generation was reduced by c-Src
inhibition, suggesting that LPS induced VCAM-1 expres-
sion via c-Src/NADPH oxidase/ROS in HRMCs. Nox4
was shown to interact with TLR4 and to be required for
LPS-induced ROS production [38,39]. It has been shown
that Nox2 is required for TLR4-mediated ROS generation
[40]. Here, we found that LPS stimulated the formation of
TLR4/c-Src/p47phox complex. Therefore, we suggested
that LPS could stimulate the protein-protein interactions
among TLR4, c-Src, and Nox2 or Nox4, and then increase
the generation of ROS. Although the detail protein-
protein interactions among TLR4, c-Src, and p47phox are
Figure 8 Schematic representation of the signaling pathways involved in the LPS-induced inflammatory responses. LPS induced ROS
production through TLR4/MyD88/c-Src/NADPH oxidase, in turn initiates the activation of p38 MAPK and ATF2. Activated ATF2 was recruited to
the promoter region of VCAM-1 leading to an increase of VCAM-1 promoter activity and the expression of VCAM-1. Up-regulation of VCAM-1
enhances the adhesion of THP-1 ells to HRMCs challenged with LPS.
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novel role of TLR4/MyD88/c-Src/p47phox complex for-
mation in LPS-induced NADPH oxidase activation and
ROS production in HRMCs. In the future, we will fur-
ther determine which domains of TLR4, MyD88, c-Src,
and p47phox are involved in protein-protein interac-
tions caused by LPS.
The MAPKs regulate diverse cellular programs by relay-
ing extracellular signals to intracellular responses. In
mammals, there are more than a dozen MAPK enzymes
that coordinately regulate cell proliferation, differentiation,
motility, and survival. The best known are the conven-
tional MAPKs, which include the extracellular signal-
regulated kinases 1 and 2 (ERK1/2), c-Jun amino-terminal
kinases 1 to 3 (JNK1 to −3), p38 (α, β, γ, and δ), and ERK5
families [41]. MAPKs also have been shown to regulate
VCAM-1 induction [23,25]. Moreover, this is confirmed
by our observation that LPS-induced VCAM-1 expression
was reduced by inhibition of p38 MAPK, JNK1/2, or p42/
p44 MAPK. ROS have been shown to stimulate p38
MAPK activation [42]. In this study, we demonstrated that
LPS-stimulated p38 MAPK, but not p42/p44 MAPK or
JNK1/2 activation was mediated through NADPH oxi-
dase/ROS in HRMCs. Thus, we suggested that p38 MAPK
mainly plays a key role in LPS-induced NADPH oxidase/
ROS-dependent VCAM-1 expression. AP-1 proteins are
implicated in the regulation of various cellular processesincluding proliferation and survival, differentiation,
growth, apoptosis, cell migration, and transformation [43].
AP-1 refers to a mixture of dimers formed between mem-
bers of the Jun, Fos, and ATF families. Moreover, p38
MAPK has been shown to mediate ATF2 phosphorylation
[44]. Here, we showed that LPS markedly induced ATF2
activation, which was reduced by p38 MAPK inhibition.
Thus, we demonstrated that LPS induced VCAM-1 ex-
pression via ROS/p38 MAPK/ATF2 in HRMCs.
The transcriptional coactivator p300 is a ubiquitous
nuclear phosphoprotein and transcriptional cofactor
with intrinsic acetyltransferase activity. p300 controls
the expression of numerous genes in a cell-type and
signal-specific manner, and plays a pivotal role in cellu-
lar proliferation, apoptosis, and embryogenesis [45]. By
catalyzing acetylation of histones and transcription fac-
tors, p300 plays a significant role in epigenetic regula-
tion. Recent evidence suggests that abnormal p300
function is associated with deregulated target gene ex-
pression, and is implicated in inflammation [45,46]. This
is confirmed by our observation that LPS-induced
VCAM-1 expression was reduced by inhibition of p300.
Moreover, LPS directly stimulated p300 phosphoryl-
ation and the formation of ATF2/p300 complex via
c-Src/ROS/p38 MAPK. Taken together, we demon-
strated that LPS could trigger renal inflammation via
p300-dependent VCAM-1 induction.
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In summary, as depicted in Figure 8, our results showed
that in HRMCs, LPS induced ROS production through
TLR4/MyD88/c-Src/Nox2 or Nox4, in turn initiates the
activation of p38 MAPK and ATF2. Activated ATF2 was
recruited to the promoter region of VCAM-1 leading to
an increase of VCAM-1 promoter activity and the expres-
sion of VCAM-1. These results provide new insights into
the mechanisms of LPS action on HRMCs to regulate the




Anti-VCAM-1, anti-TLR2, anti-TLR4, anti-MyD88, anti-
Nox2, anti-Nox4, anti-p47phox, anti-Gsα, anti-c-Src, anti-
β-actin, anti-p38 MAPK, anti-ATF2, and anti-p300
antibodies were from Santa Cruz (Santa Cruz, CA). Anti-
GAPDH antibody was from Biogenesis (Boumemouth,
UK). Anti-phospho-p38 MAPK, anti-phospho-p42/p44
MAPK, anti-phospho-JNK1/2, anti-phospho-c-Src, anti-
phospho-ATF2, and anti-phospho-p300 antibodies were
from Cell Signaling (Danver, MA). Diphenyleneiodonium
chloride (DPI), SP600125, U0126, SB202190, GR343, and
PP1 were from Biomol (Plymouth Meeting, PA). 5-(and-
6)-chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate,
acetyl ester (CM-H2DCFDA), 2’,7’-bis-(2-carboxyethyl)-5-
(and-6)-carboxyfluorescein, acetoxymethyl ester (BCECF/
AM), and dihydroethidium were from Molecular Probes
(Eugene, OR). Edaravone (MCI-186) was from Tocris Bio-
science (Ellisville, MO). Apocynin (APO) was purchased
from ChromaDex (Santa Ana, CA). LPS, enzymes, and
other chemicals were from Sigma (St. Louis, MO).
Cell culture
Human renal mesangial cells (HRMCs) were from Scien-
Cell Research Laboratories (San Diego, CA). Cells were
cultured in DMEM/F12 supplemented with 10% FBS and
antibiotics (100 U/ml penicillin G, 100 μg/ml streptomycin,
and 250 ng/ml fungizone) at 37°C in a humidified 5% CO2
atmosphere. Experiments were performed with cells from
passages 4 to 8.
Measurement of intracellular ROS accumulation
The intracellular H2O2 levels were determined by meas-
uring fluorescence of DCFH-DA, and the O2
•− levels were
determined by measuring the fluorescence of DHE. The
fluorescence intensities of DCF and DHE staining were
detected at 495/529 and 518/605 nm, respectively, using
a fluorescence microscope (Zeiss, Axiovert 200 M). In
addition, HRMCs were washed with warm HBSS and
incubated in HBSS containing 10 μM DCFH-DA or DHE
at 37°C for 30 min. and then replaced with a freshmedium. HRMCs were incubated with various concen-
trations of LPS for the indicated time intervals. Cells
were washed twice with PBS and detached with trypsin/
EDTA, and the fluorescence intensity of the cells was
analyzed using a FACScan flow cytometer (BD Bios-
ciences, San Jose, CA) at 518 nm excitation and 605 nm
emission for DHE and at 495-nm excitation and 529 nm
emission for DCF.
Determination of NADPH oxidase activity by
chemiluminescence assay
After incubation with LPS, cells were gently scraped and
centrifuged at 400 × g for 10 min at 4°C. The cell pellet
was resuspended with 35 μl/per well of ice-cold RPMI-
1640 medium, and the cell suspension was kept on ice. To
a final 200 μl volume of pre-warmed (37°C) RPMI-1640
medium containing either NADPH (1 μM) or lucigenin
(20 μM), 5 μl of cell suspension (0.2 × 105 cells) was added
to initiate the reaction followed by immediate measure-
ment of chemiluminescence in an Appliskan luminometer
(ThermoW) in an out-of-coincidence mode. Appropriate
blanks and controls were established, and chemilumines-
cence was recorded. Neither NADPH nor NADH
enhanced the background chemiluminescence of lucigenin
alone (30–40 counts per min). Chemiluminescence was
continuously measured for 12 min, and the activity of
NADPH oxidase was expressed as counts per million
cells.
Western blot analysis
Growth-arrested cells were incubated with LPS at 37°C
for the indicated time intervals. The cells were washed,
scraped, collected, and centrifuged at 45000 × g at 4°C for
1 h to yield the whole cell extract, as previously described
[9]. Samples were denatured, subjected to SDS-PAGE
using a 12% running gel, and transferred to nitrocellulose
membrane. Membranes were incubated with an anti-
VCAM-1 antibody for 24 h, and then incubated with an
anti-mouse horseradish peroxidase antibody for 1 h. The
immunoreactive bands were detected by ECL reagents.
RT-PCR analysis
Total RNA was isolated with Trizol according to the
protocol of the manufacturer. The cDNA obtained from
0.5 μg total RNA was used as a template for PCR
amplification as previously described [9]. The primers
used were as follows: 5’-TGACGGGGTCACCCAC
ACTGTGCCCATCTA-3’ (sense) and 5’-CTAGAAG
CATTTGCGGTGGACGATG-3’ (anti-sense) for β-actin;
5’-GGAACCTTGCAGCTTACAGTGACAGAGCTCCC-3’
(sense) 5’-CAAGTCTACATATCACCCAAG-3’ (anti-sense)
for VCAM-1; and ;5’-TGGATACGTTTCCTTATAAG-3’
(sense) and 5’-GAAATGGAGGCACCCCTTC-3’ (anti-
sense) for TLR4.
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Total RNA was extracted using TRIzol reagent. mRNA
was reverse-transcribed into cDNA and analyzed by real-
time RT-PCR. Real-time PCR was performed using SYBR
Green PCR reagents (Applied Biosystems, Branchburg,
NJ) and primers specific for VCAM-1 and GAPDH
mRNAs. The levels of VCAM-1 expression were deter-
mined by normalizing to GAPDH expression.
Transient transfection with siRNAs
The small interfering RNA (siRNA) duplexes correspond-
ing to human Nox2, Nox4, TLR2, TLR4, MyD88, p47phox,
c-Src, p38 MAPK, ATF2, and p300 and scrambled siRNA
were from Invitrogen (Carlsbad, CA). Transient transfec-
tion of siRNAs was carried out using Metafectene trans-
fection reagent from Biontex Lab (GmbH, Planegg/
Martinsried, Germany). siRNA (100 nM) was formulated
with Metafectene transfection reagent according to the
manufacturer's instruction.
Isolation of cell fractions
Cells were harvested, sonicated for 5 s at output 1.5 with a
sonicator (Misonix Inc., Farmingdale, NY), and centri-
fuged at 8000 rpm for 15 min at 4°C. The pellet was col-
lected as the nuclear fraction. The supernatant was
centrifuged at 14000 rpm at 4°C for 60 min to yield the
pellet (membrane fraction) and the supernatant (cytosolic
fraction).
Measurement of VCAM-1 luciferase activity
For construction of the VCAM-1-luc plasmid, human
VCAM-1 promoter, a region spanning −1716 to −119 bp
(kindly provided by Dr. W.C. Aird, Department of Molecu-
lar Medicine, Beth Israel Deaconess Medical Center, Bos-
ton, MA) was cloned into pGL3-basic vector (Promega,
Madison, WI). VCAM-1-luc activity was determined using
a luciferase assay system, as previously described [25]
(Promega, Madison, WI).
Adhesion assay
HRMCs were grown to confluence in 6-well plates with
coverslips, incubated with LPS for 16 h, and then adhe-
sion assays were performed. Briefly, THP-1 cells (human
acute monocytic leukemia cell line) were labeled with a
fluorescent dye, 10 μM BCECF/AM, at 37°C for 1 h in
RPMI-1640 medium (Gibco BRL, Grand Island, NY) and
subsequently washed with PBS followed by centrifuga-
tion. Confluent HRMCs in 6-well plates were incubated
with THP-1 cells (2 × 106 cells/ml) at 37°C for 1 h. Non-
adherent THP-1 cells were removed and plates were gen-
tly washed twice with PBS. The numbers of adherent
THP-1 cells were determined by counting four fields per
200X high-power field well using a fluorescencemicroscope (Zeiss, Axiovert 200 M). Experiments were
performed in triplicate and repeated at least three times.
Co-immunoprecipitation assay
Cell lysates containing 1 mg of protein were incubated
with 2 μg of an anti-c-Src or anti-p300 antibody at 4°C for
24 h, and then 10 μl of 50% protein A-agarose beads was
added and mixed at 4°C for 24 h. The immunoprecipitates
were collected and washed thrice with a lysis buffer with-
out Triton X-100. 5X Laemmli buffer was added and sub-
jected to electrophoresis on SDS-PAGE, and then blotted
using an anti-TLR4, anti-p47phox, anti-c-Src, anti-p300, or
anti-ATF2 antibody.
Analysis of data
Data were estimated using a GraphPad Prism Program
(GraphPad, San Diego, CA). Quantitative data were
expressed as the means ± SEM and analyzed by one-way
ANOVA followed with Tukey’s post-hoc test. P < 0.05 was
considered significant.
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